The Mouse Breeding Core (Core C) will generate, house, and maintain the final breeders needed to obtain the single and combined gene targeted and transgenic mice needed for all projects of the Program Project Grant (PPG). Once obtained, these animals will be turned over to individual investigators of the projects of the PPG for large-scale breedings to generate the required numbers of animals for the studies proposed. The animal complex is directed by a veterinarian and board certified veterinary pathologist, Dr. Mark A. Suckow, who establishes the policies regarding animal care and breeding. An associate director manages day-to-day supervision of the ten technologists who care for the animals and establish the requested breedings. Three of these latter individuals are assigned to animals of the W.M. Keck Center for Transgene Research that will be used in the investigations of the current PPG. The responsibilities of this core will be to generate appropriate mice that when bred by investigators will lead to a high statistical probability of obtaining the specific animals needed for the studies. Given the complexities of the genetic strains of the final animals in these projects, strains with low probabilities of generating the final animals will be first required. Core C will assume responsibility for this latter task.
The aims of this core are to generate at a minimum: 1) X[+/-] or X[-/-] (when mice with this genotype are able to survive and breed) mice and X+/-/Y-/- (where Y is a second gene) or X-/-/Y-/- for large-scale breedings to generate animals required for Project by Castellino; 2) APC[Min+/-o]/X+/- (or X-/-, if they survive and breed) mice for large-scale breedings for Project by Ploplis; and 3) to generate sufficient numbers of WT and FX+/- breeders for Project by Rosen.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL073750-03
Application #
7228999
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Project Start
2006-05-01
Project End
2009-04-30
Budget Start
2006-05-01
Budget End
2007-04-30
Support Year
3
Fiscal Year
2006
Total Cost
$175,844
Indirect Cost
Name
University of Notre Dame
Department
Type
DUNS #
824910376
City
Notre Dame
State
IN
Country
United States
Zip Code
46556
Miyajima, Chiharu; Iwaki, Takayuki; Umemura, Kazuo et al. (2018) Characterization of Atherosclerosis Formation in a Murine Model of Type IIa Human Familial Hypercholesterolemia. Biomed Res Int 2018:1878964
Gupta, Kamlesh K; Xu, Zhi; Castellino, Francis J et al. (2016) Plasminogen activator inhibitor-1 stimulates macrophage activation through Toll-like Receptor-4. Biochem Biophys Res Commun 477:503-8
van Montfoort, M L; Knaup, V L; Marquart, J A et al. (2013) Two novel inhibitory anti-human factor XI antibodies prevent cessation of blood flow in a murine venous thrombosis model. Thromb Haemost 110:1065-73
Xu, Zhiliang; Kamocka, Malgorzata; Alber, Mark et al. (2011) Computational approaches to studying thrombus development. Arterioscler Thromb Vasc Biol 31:500-5
Sweet, Christopher R; Chatterjee, Santanu; Xu, Zhiliang et al. (2011) Modelling platelet-blood flow interaction using the subcellular element Langevin method. J R Soc Interface 8:1760-71
Castellino, Francis J; Donahue, Deborah L; Navari, Rudolph M et al. (2011) An accompanying genetic severe deficiency of tissue factor protects mice with a protein C deficiency from lethal endotoxemia. Blood 117:283-9
Guillen-Ahlers, Hector; Suckow, Mark A; Castellino, Francis J et al. (2010) Fas/CD95 deficiency in ApcMin/+ mice increases intestinal tumor burden. PLoS One 5:e9070
Xu, Zhi; Xu, Haifeng; Ploplis, Victoria A et al. (2010) Factor VII deficiency impairs cutaneous wound healing in mice. Mol Med 16:167-76
Cao, Chunzhang; Gao, Yamei; Li, Yang et al. (2010) The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11b. J Clin Invest 120:1971-80
Xu, Zhi; Castellino, Francis J; Ploplis, Victoria A (2010) Plasminogen activator inhibitor-1 (PAI-1) is cardioprotective in mice by maintaining microvascular integrity and cardiac architecture. Blood 115:2038-47

Showing the most recent 10 out of 49 publications